Abstract Details

Title Reduced intramuscular blood flow correlates with more severe pathology in boys with Duchenne/Becker muscular dystrophy

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) P3 - (-)

Poster/Presentation
Number 116

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Alexander R. Dietz, MD (HealthONE Neurology Specialists) PRESENTER	No disclosure on file
Anne M. Connolly, MD, FAAN (Nationwide Children's Hospital)	Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. Dr. Connolly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Connolly has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. The institution of Dr. Connolly has received research support from Muscular Dystrophy Association. The institution of Dr. Connolly has received research support from NIH.
Paul Golumbek, MD, PhD	No disclosure on file
Craig M. Zaidman, MD (Washington University in St Louis)	Dr. Zaidman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sarepta. The institution of Dr. Zaidman has received research support from Washington University in St Louis. The institution of Dr. Zaidman has received research support from Novartis.

��ɫ��